Zentalis Pharmaceuticals, Inc. Insider Trading
ZNTL
Insiders sold 135K and bought nothing on the open market.
78% of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Apr 2025.
Get an email when ZNTL's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14 | William Thurman Walters Large holder | Bought | 4,335,000 | $3.50 | $15.2M | 32% | Form 4 |
| Feb 6 – 10 | Vincent Vultaggio PAO and PFO | Sold10b5-1 plan 3 parts | 40,224 | $2.42 average | 98K | 22% | Form 4 |
| Feb 6 – 9 | Ingmar Bruns Chief Medical Officer | SoldNo plan 2 parts | 3,297 | $2.43 average | 8K | 9.0% | Form 4 |
| Feb 6 – 9 | Julia Marie Eastland CEO & President | SoldNo plan 2 parts | 8,755 | $2.43 average | 21K | 10.0% | Form 4 |
| Feb 2 – 3 | Vincent Vultaggio PAO and PFO | Sold10b5-1 plan 2 parts | 3,096 | $2.54 average | 8K | 1.6% | Form 4 |
| Dec 31, 2025 | William Thurman Walters Large holder | Bought | 6,459,973 | $1.20 | $7.75M | 92% | Form 4 |
| Dec 15, 2025 | David E. Goel Large holder | SoldNo plan | 7,500,000 | $1.33 | $9.97M | 54% | Form 4 |
| Apr 30, 2025 | Scott Dunseth Myers Director | Bought | 21,000 | $1.40 | 29K | 8.1% | Form 4 |
| Feb 6, 2025 | Ingmar Bruns Chief Medical Officer | Bought | 20,000 | $2.28 | 46K | 120% | Form 4 |
| Feb 3, 2025 | Vincent Vultaggio PAO and Interim PFO | SoldNo plan | 2,615 | $1.71 | 4K | 1.4% | Form 4 |
| Feb 3, 2025 | Mark Lackner Chief Scientific Officer | SoldNo plan | 14,368 | $1.71 | 25K | 2.7% | Form 4 |
| Feb 3, 2025 | Andrea Paul Chief Legal Officer | SoldNo plan | 13,230 | $1.71 | 23K | 1.2% | Form 4 |
| Jan 31, 2025 | Jan Skvarka Director | Bought | 60,000 | $1.72 | 103K | 67% | Form 4 |
| Jan 31, 2025 | Luke Nathaniel Walker Director | Bought | 14,200 | $1.76 | 25K | 20% | Form 4 |
| Jan 31, 2025 | Julia Marie Eastland CEO & President | Bought | 28,500 | $1.73 | 49K | New | Form 4 |
| Jan 2, 2025 | Mark Lackner Chief Scientific Officer | SoldNo plan | 4,411 | $3.12 | 14K | 2.3% | Form 4 |
- Aug 14William Thurman WaltersLarge holder · bought 4,335,000 at $3.50$15.2M32% of stake
- Feb 6 – 1010b5-1 planVincent VultaggioPAO and PFO · sold 40,224 at avg $2.4298K22% of stake
- Feb 6 – 9No planIngmar BrunsChief Medical Officer · sold 3,297 at avg $2.438K9.0% of stake
- Feb 6 – 9No planJulia Marie EastlandCEO & President · sold 8,755 at avg $2.4321K10.0% of stake
- Feb 2 – 310b5-1 planVincent VultaggioPAO and PFO · sold 3,096 at avg $2.548K1.6% of stake
- Dec 31, 2025William Thurman WaltersLarge holder · bought 6,459,973 at $1.20$7.75M92% of stake
- Dec 15, 2025No planDavid E. GoelLarge holder · sold 7,500,000 at $1.33$9.97M54% of stake
- Apr 30, 2025Scott Dunseth MyersDirector · bought 21,000 at $1.4029K8.1% of stake
- Feb 6, 2025Ingmar BrunsChief Medical Officer · bought 20,000 at $2.2846K120% of stake
- Feb 3, 2025No planVincent VultaggioPAO and Interim PFO · sold 2,615 at $1.714K1.4% of stake
- Feb 3, 2025No planMark LacknerChief Scientific Officer · sold 14,368 at $1.7125K2.7% of stake
- Feb 3, 2025No planAndrea PaulChief Legal Officer · sold 13,230 at $1.7123K1.2% of stake
- Jan 31, 2025Jan SkvarkaDirector · bought 60,000 at $1.72103K67% of stake
- Jan 31, 2025Luke Nathaniel WalkerDirector · bought 14,200 at $1.7625K20% of stake
- Jan 31, 2025Julia Marie EastlandCEO & President · bought 28,500 at $1.7349KNew position
- Jan 2, 2025No planMark LacknerChief Scientific Officer · sold 4,411 at $3.1214K2.3% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ZNTL
Held by ETFs
ZNTL is in 5 US ETFs. The largest of them, with ZNTL's weight in each:
Spot a number that looks wrong? Check it in ZNTL's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ZNTL
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.